Literature DB >> 23882067

Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality.

Oktay Tutarel1, Aleksander Kempny, Rafael Alonso-Gonzalez, Richard Jabbour, Wei Li, Anselm Uebing, Konstantinos Dimopoulos, Lorna Swan, Michael A Gatzoulis, Gerhard-Paul Diller.   

Abstract

AIMS: The population of adults with congenital heart disease (ACHD) is growing and ageing. Limited information about the diagnostic spectrum of this emerging population, its resource utilization at tertiary ACHD centres, and especially about prognostic parameters is available. METHODS AND
RESULTS: Retrospective cohort study on all ACHD patients ≥60 years of age under active follow-up. All-cause mortality was the primary outcome measure. Out of a total population of 7315 ACHD patients, 375 [190 females (50.7%), mean age 64.8 ± 5.9 years] fulfilled the inclusion criteria. During a median follow-up of 5.5 (IQR 3.1-8.6) years, 55 of the 375 patients died. The number of interventions (P = 0.0006), the number and length of hospitalization (P < 0.0001), and the number of outpatient clinic visits (P < 0.0001) were significantly higher in patients ≥60 compared with patients aged between 20 and 60 years. Patients ≥60 years of age with moderate or severe congenital heart defects had worse survival prospects than their age- and gender-matched comparison population. On multivariate Cox analysis, coronary artery disease [hazard ratio (HR): 5.04; 95%CI: 1.88-13.51, P = 0.0014], symptoms of heart failure (HR: 2.36; 95%CI: 1.05-5.29, P < 0.05), NYHA class (HR: 1.96; 95%CI: 1.18-3.26, P < 0.01), and moderate to severe reduction in systemic ventricular systolic function (HR: 1.90; 95%CI: 1.20-2.99, P < 0.001) were the strongest prognostic factors.
CONCLUSION: There is a growing number of elderly ACHD patients with high mortality rates and a higher utilization of healthcare resources compared with younger patients. Acquired morbidities, such as coronary artery disease, seem to be key determinants of outcome in this older population in conjunction with the underlying congenital heart disease.

Entities:  

Keywords:  Adult congenital heart disease; Coronary artery disease; Outcome

Mesh:

Year:  2013        PMID: 23882067     DOI: 10.1093/eurheartj/eht257

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  45 in total

1.  Short-Term Costs and Hospitalization Rates in Patients With Adult Congenital Heart Disease After Pulmonic Valve Replacement.

Authors:  Deana Mikhalkova; Eric Novak; Ari Cedars
Journal:  Am J Cardiol       Date:  2016-08-22       Impact factor: 2.778

Review 2.  Current spectrum, challenges and new developments in the surgical care of adults with congenital heart disease.

Authors:  Jürgen Hörer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

3.  Quality of life in adults living with congenital heart disease: beyond morbidity and mortality.

Authors:  Amanda L Hunter; Lorna Swan
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  Hospital resource utilization and presence of advance directives at the end of life for adults with congenital heart disease.

Authors:  Jill M Steiner; James N Kirkpatrick; Susan R Heckbert; James Sibley; James A Fausto; Ruth A Engelberg; J Randall Curtis
Journal:  Congenit Heart Dis       Date:  2018-09-19       Impact factor: 2.007

Review 5.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

6.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

7.  Invited Commentary: The specialty of adult congenital heart disease.

Authors:  Ari M Cedars
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

8.  Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias.

Authors:  Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-05-07       Impact factor: 29.983

Review 9.  Burden of Heart Failure in Adults with Congenital Heart Disease.

Authors:  Laith I Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Heart Fail Rep       Date:  2016-10

10.  HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Authors:  Juan Wang; Xiao-Qing Hu; Yu-Han Guo; Jian-Yun Gu; Jia-Hong Xu; Yan-Jie Li; Ning Li; Xiao-Xiao Yang; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.